glp-1 usage statistics Ozempic Statistics: Weight Loss Medication Data GLP-1 Drug Market: the rapid

This research specifically focused on people with type 2 diabetes, so more research is needed in other groups, and the results should not be generalized

In roughly 30 years

Topline results announced in December 2025 were positive, showing that orforglipron maintained weight loss after the switch

Constipation affects 511% of users and can persist longer than nausea because your gut motility changes continue as long as you take the medication

Drucker and Holst, 2023) (Figure 1)

Tirzepatide Weekly Dosage Chart Weeks 5-8: 5.0 mg Weeks 9-12: 7.5 mg Weeks 13-16: 10.0 mg Week 20: 15 mg Are there advantages to microdosing versus full-strength prescription dosing